204 related articles for article (PubMed ID: 31315653)
21. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
[TBL] [Abstract][Full Text] [Related]
22. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of miR‑214 attenuates the migration and invasion of triple‑negative breast cancer cells.
Zhang Y; Zhao Z; Li S; Dong L; Li Y; Mao Y; Liang Y; Tao Y; Ma J
Mol Med Rep; 2019 May; 19(5):4035-4042. PubMed ID: 30942417
[TBL] [Abstract][Full Text] [Related]
24. HAT1 Coordinates Histone Production and Acetylation via H4 Promoter Binding.
Gruber JJ; Geller B; Lipchik AM; Chen J; Salahudeen AA; Ram AN; Ford JM; Kuo CJ; Snyder MP
Mol Cell; 2019 Aug; 75(4):711-724.e5. PubMed ID: 31278053
[TBL] [Abstract][Full Text] [Related]
25. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
Gohr K; Hamacher A; Engelke LH; Kassack MU
BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507
[TBL] [Abstract][Full Text] [Related]
27. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
28. 6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
Huang HY; Chang HF; Tsai MJ; Chen JS; Wang MJ
J Neuroinflammation; 2016 Apr; 13(1):78. PubMed ID: 27075886
[TBL] [Abstract][Full Text] [Related]
29. Dynamic regulation of histone H3 lysine (K) acetylation and deacetylation during prolonged oxygen deprivation in a champion anaerobe.
Wijenayake S; Storey KB
Mol Cell Biochem; 2020 Nov; 474(1-2):229-241. PubMed ID: 32729004
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.
Anestis A; Sarantis P; Theocharis S; Zoi I; Tryfonopoulos D; Korogiannos A; Koumarianou A; Xingi E; Thomaidou D; Kontos M; Papavassiliou AG; Karamouzis MV
J Cancer Res Clin Oncol; 2019 May; 145(5):1221-1233. PubMed ID: 30805773
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of Histone H2AX at Lys 5 by the TIP60 Histone Acetyltransferase Complex Is Essential for the Dynamic Binding of NBS1 to Damaged Chromatin.
Ikura M; Furuya K; Matsuda S; Matsuda R; Shima H; Adachi J; Matsuda T; Shiraki T; Ikura T
Mol Cell Biol; 2015 Dec; 35(24):4147-57. PubMed ID: 26438602
[TBL] [Abstract][Full Text] [Related]
32. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
33. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
34. Histone acetyl transferases and their epigenetic impact on bone remodeling.
Gomathi K; Akshaya N; Srinaath N; Rohini M; Selvamurugan N
Int J Biol Macromol; 2021 Feb; 170():326-335. PubMed ID: 33373635
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Response to Everolimus in Patient-Derived Triple-Negative Breast Cancer Xenografts.
Euceda LR; Hill DK; Stokke E; Hatem R; El Botty R; Bièche I; Marangoni E; Bathen TF; Moestue SA
J Proteome Res; 2017 May; 16(5):1868-1879. PubMed ID: 28290700
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.
Dudakovic A; Evans JM; Li Y; Middha S; McGee-Lawrence ME; van Wijnen AJ; Westendorf JJ
J Biol Chem; 2013 Oct; 288(40):28783-91. PubMed ID: 23940046
[TBL] [Abstract][Full Text] [Related]
37. Histone acetylation: a key determinant of acquired cisplatin resistance in cancer.
Natu A; Verma T; Khade B; Thorat R; Gera P; Dhara S; Gupta S
Clin Epigenetics; 2024 Jan; 16(1):8. PubMed ID: 38172984
[TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
39. The histone H3 lysine 56 acetylation pathway is regulated by target of rapamycin (TOR) signaling and functions directly in ribosomal RNA biogenesis.
Chen H; Fan M; Pfeffer LM; Laribee RN
Nucleic Acids Res; 2012 Aug; 40(14):6534-46. PubMed ID: 22553361
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide ChIP-seq mapping and analysis reveal butyrate-induced acetylation of H3K9 and H3K27 correlated with transcription activity in bovine cells.
Shin JH; Li RW; Gao Y; Baldwin R; Li CJ
Funct Integr Genomics; 2012 Mar; 12(1):119-30. PubMed ID: 22249597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
